The purpose of this investigation was to obtain information on platele
t-leukocyte conjugate formation in whole blood and on factors that aff
ect it, We also measured platelet and leukocyte activation by quantita
ting the expression of CD62P and CD11b, In both cases a now cytometric
approach was used, The results show that platelet-monocyte and platel
et-polymorphonuclear leukocyte (PMNL) conjugate formation is enhanced
by simply stirring blood, with optimum conjugate formation occurring a
fter 10 min, In the case of monocytes, conjugate formation was enhance
d by adenosine diphosphate (ADP), Both monocyte and PMNL conjugate for
mation was enhanced by phorbol myristate acetate (PMA), but L-formyl m
ethionyl lysyl proline (FMLP) was either without effect (monocytes) or
inhibitory (PMNL). EDTA also inhibited conjugate formation (implying
involvement of divalent cations), as did dextran sulphate (implying in
volvement of P-selectin = CD62P), Interestingly GR144053F, which acts
at GpIIb-IIIa on platelets to interfere with fibrinogen binding, and a
lso glycyl prolyl arginyl proline (GPRP), a peptide that interferes wi
th the interaction between CD11c on leukocytes and fibrinogen, did not
inhibit platelet-monocyte conjugate formation, but did inhibit the pl
atelet-PMNL interaction; this indicates that GpIIb-IIIa on platelets a
nd CD11c on leukocytes and fibrinogen are involved in mediating the in
teraction between platelets and PMNL but not platelets and monocytes,
Surprisingly arginyl glycyl aspartyl serine (RGDS) inhibited the forma
tion of both types of conjugate but this may be because it also inhibi
ted both platelet and leukocyte activation as measured by CD62P and CD
11b exposure and/or interfers with the binding of adhesion molecules o
ther than fibrinogen, The results show that a flow cytometric procedur
e can be effective in obtaining rapid information on platelet-leukocyt
e conjugate formation in whole blood and on factors that are involved
in its regulation, It is suggested that the technique may be applicabl
e to the study of platelet-leukocyte conjugate formation in whole bloo
d in disease, and also to study the effects of drugs interfering with
conjugate formation.